A frame shifted disulfide bridged analogue of angiotensin II

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 6, 2003, Pages 985-990

  Schmidt, Boris ^a   Kühn, Christian ^b   Ehlert, Dennis K ^b   Lindeberg, Gunnar ^c   Lindman, Susanna ^c   Karlén, Anders ^c   Hallberg, Anders ^c  

^a DARMSTADT UNIVERSITY OF TECHNOLOGY   (Germany)

^b LEIBNIZ UNIVERSITY HANNOVER   (Germany)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

3,5 CYCLO[ASPARTYLARGINYL (N 2 MERCAPTOETHYL)GLYCYLTYROSYL (N 2 MERCAPTOETHYL)GLYCYLHISTIDYLPROLYLPHENYLALANINE]; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN RECEPTOR; GLYCINE DERIVATIVE; N (2 MERCAPTOETHYL)GLYCINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYCLIZATION; DRUG ACTIVITY; DRUG CONFORMATION; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG SPECIFICITY; DRUG STRUCTURE; NONHUMAN; RAT; RECEPTOR AFFINITY; STRUCTURE ACTIVITY RELATION; THEORETICAL STUDY;

ANGIOTENSIN II; ANIMALS; CELL DIVISION; CHEMISTRY, PHYSICAL; CHO CELLS; CRICETINAE; DISULFIDES; INDICATORS AND REAGENTS; PEPTIDES; PROTEIN CONFORMATION; RADIOLIGAND ASSAY; RATS; RECEPTOR, ANGIOTENSIN, TYPE 1;

EID: 0037334362     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(02)00517-5     Document Type: Article

References (40)

1. Nikiforovich G. V., Marshall G. R. Biochem. Biophys. Res. Commun. 195:1993;222.
2. Cushman J. A., Mishra P. K., Bothner-By A. A., Khoshla M. S. J. Med. Chem. 32:1992;1163.
3. Shin Y. A., Yoo S. E. Biopolymers. 38:1996;183.
4. Joseph M. P., Maigret B., Scheraga H. A. Int. J. Pept. Protein. Res. 46:1995.
5. Khosla, M. C.; Smeby, R. R.; Bumpus, F. M. Structure Activity Relationship in Angiotensin II Analogues. In Handbook of Exp. Pharmacol., 1974; Vol. 37, p 126.
6. Moore, G. J. Angiotensin and Bradykinin Receptors. In Membranes and Receptors; Pergamon: Oxford, 1990; Vol. III, p 961.
7. Hodges J. C., Hamby J. M., Blankley C. J. Drugs Future. 17:1992;575.
8. 1-Rezeptorantagonisten- Angiotensin II. Dominiak P., Unger T. 1997;8 Steinkopff, Darmstadt.
9. Spear K. L., Brown M. S., Reinhard E. J., McMahon E. G., Olins G. M., Palomo M. A., Patton D. R. J. Med. Chem. 33:1990;1935.
10. Byk G., Gilon C. J. Org. Chem. 57:1992;5687.
11. Bitan G., Gilon C. Tetrahedron. 51:1995;10513.
12. Bitan G., Muller D., Kasher R., Gluhov E. V., Gilon C. J. Chem. Soc., Perkin Trans. 1. 1997;1501.
13. Bitan G., Sukhotinsky I., Mashriki Y., Hanani M., Selinger Z., Gilon C. J. Peptide Res. 49:1997;421.
14. Muller D., Zeltser I., Bitan G., Gilon C. J. Org. Chem. 62:1997;411.
15. Kaljuste K., Undén A. Int. J. Pept. Protein Res. 43:1994;505.
16. Ribera-Baeza C., Kaljuste K., Undén A. Neuropeptides. 30:1996;327.
17. Zuckermann R. N., Kerr J. M., Kent S.B.H., Moos W. H. J. Am. Chem. Soc. 114:1992;10646.
18. Coste J., Dufour M.-N., Pantaloni A., Castro B. Tetrahedron Lett. 31:1990;669.
19. Miller S. J., Grubbs R. H. J. Am. Chem. Soc. 117:1995;5855.
20. Miller S. J., Blackwell H. E., Grubbs R. H. J. Am. Chem. Soc. 118:1996;9606.
21. Grubbs R. H., Miller S. J., Fu G. C. Accounts Chem. Res. 28:1995;446.
22. Schmidt B. Journal für praktische Chemie Chemiker Zeitung. 339:1997;493.
23. Fürstner A., Langemann K. J. Am. Chem. Soc. 119:1997;9130.
24. Armstrong S. K. J. Chem. Soc., Perkin Trans. 1. 1998;371.
25. Reichwein J. F., Wels B., Kruijtzer J.A.W., Versluis C., Liskamp R.M.J. Angewandte Chem. Int. Ed. English. 38:1999;3684.
26. Reichwein J. F., Liskamp R.M.J. Eur. J. Org. Chem. 2000;2335.
27. Reichwein J. F., Versluis C., Liskamp R.M.J. J. Org. Chem. 2000;6187.
28. Mohamadi F., Richards N.G.C., Guida W. C., Liskamp R., Lipton M., Caufield C., Chang G., Hendrickson T., Still W. C. J. Comput. Chem. 11:1990;440.
29. Schmidt B., Lindman S., Tong W., Lindeberg G., Gogoll A., Lai Z., Thoernwall M., Synnergren B., Nilsson A., Welch C. J., Sohtell M., Westerlund C., Nyberg F., Karlen A., Hallberg A. J. Med. Chem. 40:1997;903.
30. Maigret B., Perahia D., Pullman B. J. Theor. Biol. 29:1970;275.
31. Stewart D. E., Sarkar A., Wampler J. E. J. Mol. Biol. 214:1990;253.
32. Lewis P. N., Momany F. A., Scheraga H. A. Biochim. Biophys. Acta. 303:1973;211.
33. Richardson J. S. Adv. Protein. Chem. 34:1981;167.
34. Smith J. A., Pease L. G. CRC Crit. Rev. Biochem. 8:1980;315.
35. Schmidt, B. Biomimetika- Ihre Synthese durch Übergangsmetall-katalysierte Schlüsselreaktionen und ihre Anwendung. Universität Hannover, 1998.
36. Perlman S., Schambye H. T., Rivero R. A., Greenlee W. J., Hjorth S. A., Schwartz T. W. J. Biol. Chem. 270:1995;1493.
37. Samanen J., Cash T., Narindray D., Brandeis E. W., Adams J., Weidman H., Yellin T. J. Med. Chem. 34:1991;3036.
38. Jorgensen E. C., Rapaka S. R., Windridge G. C., Lee T. C. J. Med. Chem. 14:1971;904.
39. Conrad R. A., Cullinan G. J., Gerzon K., Poore G. A. J. Med. Chem. 22:1979;391.
40. Still W. C., Tempczyk A., Hawley R. C., Hendrickson T. J. Am. Chem. Soc. 112:1990;6127.